Symposia on Cancer Research
MD Anderson Cancer Center has held symposia on cancer research for more than 60 years. In the early years, this meeting covered all of cancer research, providing an annual overview of new scientific findings and new developments in patient care. In recent years, more focused topics were selected, reflecting the enormous growth in the spectrum of cancer research at MD Anderson and in the field in general. Over the past decade, these topics were closely tied to our institutional research themes.
The goals of the symposia remain unchanged: to bring the leaders in a given field from all over the world to MD Anderson to allow interaction, promote collaboration and provide education for the benefit of our trainees and faculty.
All meetings are held at MD Anderson with the main venue being the Robert C. Hickey Auditorium (R11.1400), Main Building, Floor 11, near Elevator B.
October 4-5, 2013
Lynda Chin, M.D.
Andrew Futreal, Ph.D.
Funda Meric-Bernstam, M.D.
The goal of the symposium is to bring together world-renowned scientists to present and discuss novel basic, translational and clinical research being conducted in the area of genomic medicine as it relates to cancer. Topics will include: broad based efforts to catalogue and understand genomic abnormalities in cancer and the role of comprehensive computational approaches in identifying the most meaningful of them; leveraging genomic science to go beyond into drug discovery and other omics; and the application of new found knowledge to the clinic to guide new clinical trials. Keynote speakers are Arul M. Chinnaiyan, MD, PhD (University of Michigan School of Medicine) and Gad Asher Getz, PhD (Broad Institute of MIT and Harvard). In addition, Mike Stratton, PhD (Wellcome Trust Sanger Institute) and Andrew Futreal, PhD (MD Anderson) will jointly receive the Ernst W. Bertner Memorial Award. Charles L. Sawyers, MD (Memorial Sloan-Kettering Cancer Center) will receive the Heath Memorial Award.